Abstract: Provided is a self-adhesive waterproof sheet with a modified synthetic rubber and more particularly, the self-adhesive waterproof sheet with a modified synthetic rubber includes an asphalt compound layer; a protective film layer that is formed on the asphalt compound layer and is oriented in two directions with respect to elongation by mixing high density polyethylene (HDPE) and methallaocene low density polyethylene (M.PE) at a ratio of 30 wt % to 70 wt % :30 wt % to 70 wt %; and a release sheet formed to be detachably attached to a lower portion of the asphalt compound layer.

Abstract: In accordance with one embodiment, the present invention provides the ability to embed and edit rich content into a browser document. Embedded objects are not backed by installed desktop applications. Instead, in one embodiment, the embedded objects are Asynchronous Javascript and XML (AJAX) components that adhere to a set of design patterns, which are embedded within editable HTML documents. For example, a user composing an email message can embed a spreadsheet into the email in accordance with an embodiment of the present invention. The spreadsheet is implemented, in one embodiment, as an AJAX component adhering to the Ajax Linking and Embedding (ALE) design pattern. Since it is an ALE component, the embedded object is fetched across the network so that it may be instantiated and used regardless of the user's location. The user can edit, manipulate, and save the embedded object while remaining in the context of the container document.

Abstract: The present invention relates to a novel 4-((2-acrylamidophenyl)amino)thieno[3,2-d]pyrimidine-7-carboxamide compound, an anticancer agent containing the compound as an active ingredient and an intermediate compound for preparing the compound.

Abstract: The present invention relates to various processes by a template-dependent extension reaction using a dual specificity oligonucleotide and a dual specificity oligonucleotide composed of three different Tm portions therefor. Demonstrated in the present invention are the features of the dual specificity oligonucleotide, which are high hybridization specificity and mismatch tolerance.

Abstract: The present invention relates to the detection of a target nucleic acid sequence by a PCE-SH (PTO Cleavage and Extension-Dependent Signaling Oligonucleotide Hybridization) assay. The present invention does not use probes to be hybridized with target nucleic acid sequences for providing target signals. Interestingly, the present invention uses probes (signaling oligonucleotides) to be hybridized with the extended strand formed in a target-dependent manner in which the extended strand is synthesized using the CTO artificially selected as templates.

Abstract: A method of performing cross-authentication in a vehicle controller interworking with an external device includes: generating a random number S and transmitting the random number S to the external device according to an authentication request message received from the external device; generating a variable i using a first function having the random number S as a parameter; generating a first session key Ks using a second function having the variable i and a pre-stored secret key K as parameters; receiving a first response key from the external device; generating a second response key using a third function having the random number S, the variable i and the first session key Ks as parameters; and authenticating the external device based on whether the first response key is equal to the second response key.

Abstract: Systems and methods may utilize cutaneous feedback for enhanced control of various types of manipulandum. Embodiments of the present invention may include a haptic feedback system comprising: an actuator that exerts force to a user when engaging the actuator that provides cutaneous feedback to the user when using the system. The systems and methods may allow for adjustable and customizable operation of the system to improve the relationship between human and mechanical or virtual devices.

Abstract: The present invention provides a pharmaceutical composition, as an effective ingredient, a urea compound having a protein kinase inhibitory activity and containing a 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one skeleton, and a pharmaceutically acceptable salt thereof.

Abstract: The present invention provides a therapeutic agent of acute myeloid leukemia containing a 1,3,7-trisubstituted 3,4-dihydropyrimido[4,5-d]pyrimidine-2(1H)-one compound as an active ingredient, which has proliferation inhibitory activity for a human acute myeloid leukemia cell line OCI-AML3 having a NRAS mutant gene while having low inhibitory activity for wild type NRAS and has activity of inhibiting GCK and ACK1 protein kinases at the same time.

Abstract: There are provided an inductor and a method of manufacturing the same. The inductor includes: a body including a plurality of coil layers and high-rigidity insulating layers disposed on and beneath the plurality of coil layers; and external electrodes disposed on external surfaces of the body and connected to the coil layers. Build-up insulating layers are disposed between the high-rigidity insulating layers to cover the coil layers, and the high-rigidity insulating layers have a Young's modulus greater than that of the build-up insulating layers.

Abstract: The present invention relates to the detection of a target nucleic acid sequence by a PCE-NH (PTO Cleavage and Extension-Dependent Non-Hybridization) assay. The present invention adopts the occurrence of the inhibition of the hybridization between the HO with the CTO by the formation of the target-dependent extended duplex. Therefore, the present invention may detect target sequences even when the HO is not cleaved. In this regard, the design of the 5?-tagging portion of PTO, CTO and HO sequences may be readily performed and the conditions for reactions may be also easily established. In addition, the detection of the hybrid between the CTO and the HO may be performed in a different vessel from that for the extension of the CTO.

Abstract: The present disclosure provides a method and a receiver for detecting synchronization in a Time Division-Synchronous Code Division Multiple Access (TD-SCDMA) system. The receiver includes a reception unit that receives a synchronization signal including an interference signal from at least one adjacent cell; and a synchronization detector that cancels the interference signal included in the synchronization signal based on a serial interference cancellation, and detects the synchronization based on the synchronization signal, from which the interference signal is canceled.

Abstract: The present invention relates to a therapeutic agent for chronic myelogenous leukemia with reduced drug-resistance and side-effects containing a 1,6-disubstituted indole compound.

Abstract: The present invention relates to a novel method for detection of target nucleic acid sequences on a solid phase using dual-labeled immobilized probes and its resistance to a 5? to 3? exonuclease activity of a DNA polymerase. Because the label is remained on the solid substrate by resistance to nucleases due to labeling of a base component the internal nucleotide, the present invention requires no consideration of a suitability of position of the label for remaining on the solid substrate. The present invention ensures to minimize background signal by positioning labels at a site on probes suitable to maximize quenching efficiency of the dual label system, since it permits to freely determine the position of the internal label on probes.

Abstract: The present invention relates to various processes by a template-dependent extension reaction using a dual specificity oligonucleotide and a dual specificity oligonucleotide composed of three different Tm portions therefor. Demonstrated in the present invention are the features of the dual specificity oligonucleotide, which are high hybridization specificity and mismatch tolerance.